Assembly Biosciences Inc — Liquidità Trimestrale (NASDAQ:ASMB) | MetaTrader

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Totale attivo 119.17 M99.02 M80.78 M240 M257.59 M Totale passività 85.81 M71.88 M62.68 M57.3 M50.84 M Patrimonio netto totale 33.36 M27.13 M18.1 M182.69 M206.75 M Totale passività e patrimonio netto 119.17 M99.02 M80.78 M240 M257.59 M Debito totale ————— Indebitamento netto —————

Notizie

Assembly Bio presenterà dati su farmaco per herpes a ESCMID

Guggenheim alza il target di prezzo di Assembly Biosciences per i progressi sul farmaco per l’herpes

Assembly Biosciences: 'Buy' On HPI Program Opt-In And HDV Candidate Development (ASMB)

Assembly Biosciences (ASMB) Q4 Earnings and Revenues Top Estimates

Metagenomi Therapeutics (MGX) Reports Q4 Loss, Misses Revenue Estimates

Personalis (PSNL) Reports Q4 Loss, Misses Revenue Estimates

Supernus Pharmaceuticals (SUPN) Surpasses Q4 Earnings and Revenue Estimates

GILD Exercises Option to License Assembly Bio's Herpes Programs

Gilead Sciences Bets On Weekly Pill To Tackle Genital Herpes - Assembly Biosciences (NASDAQ:ASMB), Gilead Sciences (NASDAQ:GILD)

Gilead exercises option for Assembly Bio’s herpes treatment programs

Jefferies alza il target di prezzo di Assembly Biosciences a $62 sui dati HSV

Jefferies raises Assembly Biosciences stock price target to $62 on HSV data